首页 > 最新文献

Journal of Obstetrics and Gynecology of India最新文献

英文 中文
Human Embryo Quality Assessment with Deep Learning Models. 人类胚胎质量评估与深度学习模型。
IF 0.7 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-01 Epub Date: 2025-04-26 DOI: 10.1007/s13224-025-02109-5
Maryam Kalatehjari, Younes Ghasemi, Shaghayegh Mahmoudiandehkordi, Fatemeh Afrazeh, Hossein Abbasi, Fariba Ghasemi

Background: Embryo quality assessment plays a pivotal role in assisted reproductive technology (ART) for selecting viable embryos for implantation. Accurate evaluation is essential for improving success rates in fertility treatments. Traditional assessment methods rely on subjective visual grading by embryologists, which can lead to inconsistencies. The application of deep learning in this domain offers the potential for objective and reproducible assessments.

Materials and methods: This study investigates the use of deep learning models to classify embryo images as good or not good at the day-3 and day-5 stages. A dataset obtained from Hung Vuong Hospital in Ho Chi Minh City was used to train and evaluate four convolutional neural network (CNN) architectures: VGG-19, ResNet-50, InceptionV3, and EfficientNetV2. Performance metrics, including accuracy, precision, and recall, were used to assess model effectiveness.

Results: Among the tested models, EfficientNetV2 demonstrated superior performance, achieving an accuracy of 95.26%, a precision of 96.30%, and a recall of 97.25%. These results indicate that deep learning models, particularly EfficientNetV2, can provide highly accurate and consistent assessments of embryo quality.

Conclusion: The high classification accuracy of EfficientNetV2 underscores its potential as a valuable tool for fertility specialists. By offering objective and consistent evaluations, this approach can enhance fertility treatment efficiency and support prospective parents in their reproductive journey.

背景:胚胎质量评估在辅助生殖技术(ART)中选择可行的胚胎进行着床起着关键作用。准确的评估对提高生育治疗的成功率至关重要。传统的评估方法依赖于胚胎学家的主观视觉评分,这可能导致不一致。深度学习在这一领域的应用为客观和可重复的评估提供了潜力。材料和方法:本研究探讨了在第3天和第5天阶段使用深度学习模型对胚胎图像进行良好或不好的分类。从胡志明市Hung Vuong医院获得的数据集用于训练和评估四种卷积神经网络(CNN)架构:VGG-19、ResNet-50、InceptionV3和EfficientNetV2。性能指标,包括准确性、精密度和召回率,被用来评估模型的有效性。结果:在所测试的模型中,EfficientNetV2表现出优异的性能,准确率为95.26%,精密度为96.30%,召回率为97.25%。这些结果表明,深度学习模型,特别是EfficientNetV2,可以提供高度准确和一致的胚胎质量评估。结论:高效netv2具有较高的分类准确率,为生育专家提供了一个有价值的工具。通过提供客观和一致的评估,这种方法可以提高生育治疗效率,并支持准父母的生育之旅。
{"title":"Human Embryo Quality Assessment with Deep Learning Models.","authors":"Maryam Kalatehjari, Younes Ghasemi, Shaghayegh Mahmoudiandehkordi, Fatemeh Afrazeh, Hossein Abbasi, Fariba Ghasemi","doi":"10.1007/s13224-025-02109-5","DOIUrl":"10.1007/s13224-025-02109-5","url":null,"abstract":"<p><strong>Background: </strong>Embryo quality assessment plays a pivotal role in assisted reproductive technology (ART) for selecting viable embryos for implantation. Accurate evaluation is essential for improving success rates in fertility treatments. Traditional assessment methods rely on subjective visual grading by embryologists, which can lead to inconsistencies. The application of deep learning in this domain offers the potential for objective and reproducible assessments.</p><p><strong>Materials and methods: </strong>This study investigates the use of deep learning models to classify embryo images as good or not good at the day-3 and day-5 stages. A dataset obtained from Hung Vuong Hospital in Ho Chi Minh City was used to train and evaluate four convolutional neural network (CNN) architectures: VGG-19, ResNet-50, InceptionV3, and EfficientNetV2. Performance metrics, including accuracy, precision, and recall, were used to assess model effectiveness.</p><p><strong>Results: </strong>Among the tested models, EfficientNetV2 demonstrated superior performance, achieving an accuracy of 95.26%, a precision of 96.30%, and a recall of 97.25%. These results indicate that deep learning models, particularly EfficientNetV2, can provide highly accurate and consistent assessments of embryo quality.</p><p><strong>Conclusion: </strong>The high classification accuracy of EfficientNetV2 underscores its potential as a valuable tool for fertility specialists. By offering objective and consistent evaluations, this approach can enhance fertility treatment efficiency and support prospective parents in their reproductive journey.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 3","pages":"227-232"},"PeriodicalIF":0.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205116/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144530967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-op Puzzle: Deciphering Fallopian Tube Prolapse After Hysterectomy. 术后难题:解读子宫切除术后输卵管脱垂。
IF 0.7 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-01 Epub Date: 2025-05-21 DOI: 10.1007/s13224-025-02131-7
Chandana Tholu, Amruta Choudhary, Prajakta Bhimgade, Anita Yadav

Fallopian tube prolapse following hysterectomy is an uncommon condition that can be mistaken for vaginal vault granulation tissue or vaginal vault cancer. We present two cases of post-hysterectomy fallopian tube prolapse that were successfully treated using a combination of laparoscopic and vaginal approaches. Performing hysterectomy combined with routine salpingectomies can prevent fallopian tube prolapse and offer additional protection against tubal and ovarian cancers.

子宫切除术后输卵管脱垂是一种罕见的情况,可被误认为阴道穹窿肉芽组织或阴道穹窿癌。我们提出了两例子宫切除术后输卵管脱垂的成功治疗使用腹腔镜和阴道途径的组合。将子宫切除术与常规输卵管切除术相结合可以预防输卵管脱垂,并为预防输卵管和卵巢癌提供额外的保护。
{"title":"Post-op Puzzle: Deciphering Fallopian Tube Prolapse After Hysterectomy.","authors":"Chandana Tholu, Amruta Choudhary, Prajakta Bhimgade, Anita Yadav","doi":"10.1007/s13224-025-02131-7","DOIUrl":"10.1007/s13224-025-02131-7","url":null,"abstract":"<p><p>Fallopian tube prolapse following hysterectomy is an uncommon condition that can be mistaken for vaginal vault granulation tissue or vaginal vault cancer. We present two cases of post-hysterectomy fallopian tube prolapse that were successfully treated using a combination of laparoscopic and vaginal approaches. Performing hysterectomy combined with routine salpingectomies can prevent fallopian tube prolapse and offer additional protection against tubal and ovarian cancers.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 3","pages":"261-263"},"PeriodicalIF":0.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12204956/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144531057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome of Early Severe Alloimmunised Pregnancies. 早期严重同种免疫妊娠的结局。
IF 0.7 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-01 Epub Date: 2025-01-24 DOI: 10.1007/s13224-024-02081-6
Kamaldeep Bains, Subhas Chandra Saha, Neelam Aggarwal, Ashish Jain, Shivsajan Saini, Anil Eragam

Purpose: To evaluate the perinatal outcome of early severely alloimmunised pregnancies.

Methods: This was a prospective observational comparative study of all Rh alloimmunised women who required IUT in less than 26 weeks of gestation. Outcome measures such as abortion, stillbirth, perinatal survival, and neonatal outcomes were compared with those who required IUT after 26 weeks gestation. Thinner needle (22G) and intrahepatic route preferentially were used for early transfusions.

Results: Out of forty-four patients, 22 required transfusion at early gestation. A total of 152 IUT's were given in both groups. Mean number of IUT's was 4.5 ± 2 and 2.2 ± 1.4 in early and late group, respectively. There were two abortions in early group. One stillbirth occurred each in early & late groups while there were three neonatal deaths in late group. Hydropic foetuses were more likely to survive when they were treated early in gestation (80% vs. 66%). Take-home baby rate was 86.3% in early group which was higher than in late transfusion group (82.6%).

Conclusion: Proper technique and appropriate skill can reduce early IUT complications and improve survival. Results can be as good as those of foetuses who have late transfusions. Hydrops foetuses are more likely to survive if diagnosed and treated early.

目的:评价早期重度同种异体免疫妊娠的围产儿结局。方法:这是一项前瞻性观察性比较研究,研究对象为妊娠26周以内接受过Rh异体免疫且需要宫内节育术的妇女。结果测量如流产、死产、围产期生存和新生儿结局比较那些在妊娠26周后需要IUT。早期输血优先采用细针(22G)和肝内途径。结果:44例患者中,22例在妊娠早期需要输血。两组共应用IUT 152次。早期组平均为4.5±2个,晚期组平均为2.2±1.4个。早期组有2例流产。早期组和晚期组各发生1例死产,而晚期组有3例新生儿死亡。妊娠早期接受治疗的积水胎儿存活率更高(80% vs 66%)。早期输血组带婴率为86.3%,高于晚期输血组(82.6%)。结论:适当的技术和技巧可减少早期IUT并发症,提高生存率。结果可以和晚期输血的胎儿一样好。如果及早诊断和治疗,积水的胎儿更有可能存活。
{"title":"Outcome of Early Severe Alloimmunised Pregnancies.","authors":"Kamaldeep Bains, Subhas Chandra Saha, Neelam Aggarwal, Ashish Jain, Shivsajan Saini, Anil Eragam","doi":"10.1007/s13224-024-02081-6","DOIUrl":"10.1007/s13224-024-02081-6","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the perinatal outcome of early severely alloimmunised pregnancies.</p><p><strong>Methods: </strong>This was a prospective observational comparative study of all Rh alloimmunised women who required IUT in less than 26 weeks of gestation. Outcome measures such as abortion, stillbirth, perinatal survival, and neonatal outcomes were compared with those who required IUT after 26 weeks gestation. Thinner needle (22G) and intrahepatic route preferentially were used for early transfusions.</p><p><strong>Results: </strong>Out of forty-four patients, 22 required transfusion at early gestation. A total of 152 IUT's were given in both groups. Mean number of IUT's was 4.5 ± 2 and 2.2 ± 1.4 in early and late group, respectively. There were two abortions in early group. One stillbirth occurred each in early & late groups while there were three neonatal deaths in late group. Hydropic foetuses were more likely to survive when they were treated early in gestation (80% vs. 66%). Take-home baby rate was 86.3% in early group which was higher than in late transfusion group (82.6%).</p><p><strong>Conclusion: </strong>Proper technique and appropriate skill can reduce early IUT complications and improve survival. Results can be as good as those of foetuses who have late transfusions. Hydrops foetuses are more likely to survive if diagnosed and treated early.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 3","pages":"220-226"},"PeriodicalIF":0.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205109/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144531056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary Cytoreductive Surgery Versus Neoadjuvant Chemotherapy Followed by Surgery in Patients with Advanced Primary Epithelial Ovarian Cancer in Low Resources Setting: A Randomized Clinical Trial. 低资源环境下晚期原发性上皮性卵巢癌患者的原发性细胞减少手术与新辅助化疗后手术:一项随机临床试验
IF 0.7 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-01 Epub Date: 2024-11-06 DOI: 10.1007/s13224-024-02061-w
Hisham Abutaleb, Ali Hussien, Mohamed Khalaf, Dalia M Badary, Alaa M Ismail, Sara Hassanein, Samy AlGizawy, S A M Moustafa, Rabab Mohmed Mumdouh Farghaly, A F Abdel-Kawi

Introduction: Ovarian cancer (OV) stands as the deadliest female reproductive system malignancy. Globally, OV ranks as the seventh most prevalent cancer in women, with an estimated 240,000 new cases annually and being the second most common malignancy among women in Egypt.

Objectives: We investigate the efficacy of cytoreductive surgery in achieving complete tumor removal (R0 resection) in OV, compared to neoadjuvant chemotherapy followed by surgery.

Method: This randomized controlled trial at Women Health Hospital, Asyut University, Egypt from 2020 to 2023. Eighty patients were randomized (1:1) to primary surgery (Group I) or NACT (Group II), followed by further randomization (1:1) within each group to bevacizumab-containing chemotherapy or chemotherapy alone. The primary outcome was the rate of complete tumor removal (R0 resection). Secondary outcomes included surgical complexity, operative time, complications, and survival rates.

Results: Baseline demographic characteristics were similar between the groups (no statistically significant differences). The mean age for group I and group II were (56.3 and 57.23, respectively). Whereas, the BMI for group I and group II were (32.56 and 33.2, respectively). In addition, both groups achieved no significant difference of complete tumor removal (31 vs. 27). However, group II demonstrated significantly shorter operative times (182.34 vs. 219.85 min, p = 0.047), required fewer blood transfusions (9 vs. 21, p value 0.006), and experienced shorter hospital stays (6.13 vs. 11.9 days, p value < 0.001) compared to group I. Notably, no significant differences emerged in complication rates, progression-free survival (11.20 vs. 11.19 months), or overall survival (11.69 vs. 11.76 months) between the groups.

Conclusion: Our study demonstrates that optimal cytoreduction is more feasible with NACT, with less surgical complexity, shorter operative duration, less blood transfusion and short hospital stay.Clinical Trials registration The study was registered on clincaltrail.gov with number: NCT04257786.

Supplementary information: The online version contains supplementary material available at 10.1007/s13224-024-02061-w.

卵巢癌(OV)是最致命的女性生殖系统恶性肿瘤。在全球范围内,OV是女性中第七大最常见的癌症,每年估计有24万新病例,是埃及女性中第二大最常见的恶性肿瘤。目的:我们研究细胞减少手术在OV中实现完全肿瘤切除(R0切除)的效果,并与新辅助化疗后手术进行比较。方法:于2020 - 2023年在埃及阿斯尤特大学妇女保健医院进行随机对照试验。80例患者随机(1:1)分为初始手术组(I组)或NACT组(II组),随后每组进一步随机(1:1)分为含贝伐单抗化疗组或单独化疗组。主要结果是肿瘤完全切除率(R0切除术)。次要结局包括手术复杂性、手术时间、并发症和生存率。结果:两组间基线人口学特征相似(无统计学差异)。I组和II组的平均年龄分别为56.3岁和57.23岁。而I组和II组的BMI分别为32.56和33.2。此外,两组肿瘤完全切除无显著差异(31 vs. 27)。II组手术时间明显缩短(182.34 vs. 219.85 min, p = 0.047),输血次数明显减少(9 vs. 21, p = 0.006),住院时间明显缩短(6.13 vs. 11.9 d, p = 0.006)。结论:我们的研究表明,采用NACT进行最佳细胞减少更可行,手术复杂性更小,手术时间更短,输血次数更少,住院时间更短。该研究已在clincaltrail.gov上注册,编号:NCT04257786。补充信息:在线版本包含补充资料,提供地址为10.1007/s13224-024-02061-w。
{"title":"Primary Cytoreductive Surgery Versus Neoadjuvant Chemotherapy Followed by Surgery in Patients with Advanced Primary Epithelial Ovarian Cancer in Low Resources Setting: A Randomized Clinical Trial.","authors":"Hisham Abutaleb, Ali Hussien, Mohamed Khalaf, Dalia M Badary, Alaa M Ismail, Sara Hassanein, Samy AlGizawy, S A M Moustafa, Rabab Mohmed Mumdouh Farghaly, A F Abdel-Kawi","doi":"10.1007/s13224-024-02061-w","DOIUrl":"10.1007/s13224-024-02061-w","url":null,"abstract":"<p><strong>Introduction: </strong>Ovarian cancer (OV) stands as the deadliest female reproductive system malignancy. Globally, OV ranks as the seventh most prevalent cancer in women, with an estimated 240,000 new cases annually and being the second most common malignancy among women in Egypt.</p><p><strong>Objectives: </strong>We investigate the efficacy of cytoreductive surgery in achieving complete tumor removal (R0 resection) in OV, compared to neoadjuvant chemotherapy followed by surgery.</p><p><strong>Method: </strong>This randomized controlled trial at Women Health Hospital, Asyut University, Egypt from 2020 to 2023. Eighty patients were randomized (1:1) to primary surgery (Group I) or NACT (Group II), followed by further randomization (1:1) within each group to bevacizumab-containing chemotherapy or chemotherapy alone. The primary outcome was the rate of complete tumor removal (R0 resection). Secondary outcomes included surgical complexity, operative time, complications, and survival rates.</p><p><strong>Results: </strong>Baseline demographic characteristics were similar between the groups (no statistically significant differences). The mean age for group I and group II were (56.3 and 57.23, respectively). Whereas, the BMI for group I and group II were (32.56 and 33.2, respectively). In addition, both groups achieved no significant difference of complete tumor removal (31 vs. 27). However, group II demonstrated significantly shorter operative times (182.34 vs. 219.85 min, <i>p</i> = 0.047), required fewer blood transfusions (9 vs. 21, <i>p</i> value 0.006), and experienced shorter hospital stays (6.13 vs. 11.9 days, <i>p</i> value < 0.001) compared to group I. Notably, no significant differences emerged in complication rates, progression-free survival (11.20 vs. 11.19 months), or overall survival (11.69 vs. 11.76 months) between the groups.</p><p><strong>Conclusion: </strong>Our study demonstrates that optimal cytoreduction is more feasible with NACT, with less surgical complexity, shorter operative duration, less blood transfusion and short hospital stay.<i>Clinical Trials registration</i> The study was registered on clincaltrail.gov with number: NCT04257786.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13224-024-02061-w.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 3","pages":"199-205"},"PeriodicalIF":0.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205117/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144531058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Co-existent Uterovaginal and Rectal Prolapse Management: A Case Series. 同时存在的子宫阴道和直肠脱垂的治疗:一个病例系列。
IF 0.7 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-01 Epub Date: 2025-04-23 DOI: 10.1007/s13224-025-02120-w
Manasi Deoghare, N Nisha, Rajesh Kumari, J B Sharma, Ashita Aggarwal, Muntaha Khan

Background: The simultaneous occurrence of uterovaginal and rectal prolapse, i.e. dual prolapse, is uncommon. However, these two conditions can be managed concurrently through a combination of perineal, abdominal and laparoscopic approaches. In this article, we present a series of four cases wherein a perineal approach was utilized successfully.

Method: All 4 patients had varying degrees of uterine prolapse, cystocele and rectocele along with external rectal prolapse. They all had completed their families and provided consent for hysterectomy. One patient underwent vaginal hysterectomy and pelvic floor repair along with the Delorme procedure for rectal prolapse, while the remaining three patients had vaginal hysterectomy and anterior colporrhaphy and posterior colpoperineorrhaphy with levatorplasty.

Results: Follow-up evaluation 6 months after surgery revealed complete resolution of symptoms with no vault prolapse and rectal prolapse on examination. It is worth noting that all surgeries were performed under spinal anaesthesia, making this approach suitable for candidates who are at high risk during general anaesthesia, thereby allowing for simultaneous treatment of uterovaginal and rectal prolapse via perineal repair techniques. Also, assistance from surgeons was taken only in one case where Delorme procedure was performed, and in rest 3 cases, satisfactory surgical outcomes were seen following a good posterior colpoperineorrhaphy.

Conclusion: Concomitant repair of both uterovaginal and rectal prolapse can be successfully performed by combining vaginal hysterectomy along with a good posterior colpoperineorrhaphy or Delorme procedure under spinal anaesthesia.

背景:同时发生子宫阴道和直肠脱垂,即双脱垂,是罕见的。然而,这两种情况可以通过会阴、腹部和腹腔镜联合入路同时处理。在这篇文章中,我们提出了一系列的四个案例,其中会阴入路被成功地利用。方法:4例患者均有不同程度的子宫脱垂、膀胱膨出、直肠膨出并直肠外脱垂。她们都已经完成了自己的家庭,并同意进行子宫切除术。1例患者行阴道子宫切除术和盆底修复术,并结合Delorme手术治疗直肠脱垂,其余3例患者行阴道子宫切除术和前阴道修补术及后阴道修补术联合提肛成形术。结果:术后6个月随访,症状完全缓解,检查无拱顶脱垂和直肠脱垂。值得注意的是,所有手术都是在脊髓麻醉下进行的,因此这种方法适用于全麻期间高危的候选人,从而允许通过会阴修复技术同时治疗子宫阴道和直肠脱垂。此外,只有一例Delorme手术得到了外科医生的帮助,其余3例手术结果令人满意,手术后阴道吻合良好。结论:在脊髓麻醉下,阴道子宫切除术联合良好的阴道后缝术或Delorme手术可成功修复子宫、阴道和直肠脱垂。
{"title":"Co-existent Uterovaginal and Rectal Prolapse Management: A Case Series.","authors":"Manasi Deoghare, N Nisha, Rajesh Kumari, J B Sharma, Ashita Aggarwal, Muntaha Khan","doi":"10.1007/s13224-025-02120-w","DOIUrl":"10.1007/s13224-025-02120-w","url":null,"abstract":"<p><strong>Background: </strong>The simultaneous occurrence of uterovaginal and rectal prolapse, i.e. dual prolapse, is uncommon. However, these two conditions can be managed concurrently through a combination of perineal, abdominal and laparoscopic approaches. In this article, we present a series of four cases wherein a perineal approach was utilized successfully.</p><p><strong>Method: </strong>All 4 patients had varying degrees of uterine prolapse, cystocele and rectocele along with external rectal prolapse. They all had completed their families and provided consent for hysterectomy. One patient underwent vaginal hysterectomy and pelvic floor repair along with the Delorme procedure for rectal prolapse, while the remaining three patients had vaginal hysterectomy and anterior colporrhaphy and posterior colpoperineorrhaphy with levatorplasty.</p><p><strong>Results: </strong>Follow-up evaluation 6 months after surgery revealed complete resolution of symptoms with no vault prolapse and rectal prolapse on examination. It is worth noting that all surgeries were performed under spinal anaesthesia, making this approach suitable for candidates who are at high risk during general anaesthesia, thereby allowing for simultaneous treatment of uterovaginal and rectal prolapse via perineal repair techniques. Also, assistance from surgeons was taken only in one case where Delorme procedure was performed, and in rest 3 cases, satisfactory surgical outcomes were seen following a good posterior colpoperineorrhaphy.</p><p><strong>Conclusion: </strong>Concomitant repair of both uterovaginal and rectal prolapse can be successfully performed by combining vaginal hysterectomy along with a good posterior colpoperineorrhaphy or Delorme procedure under spinal anaesthesia.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 3","pages":"258-260"},"PeriodicalIF":0.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12204969/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144530965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Male Age and Semen Parameters on Blastocyst Morphology, Beta-HCG Positivity and Pregnancy Viability: A Retrospective Analysis in Frozen Embryo Transfer Cycles. 男性年龄和精液参数对冷冻胚胎移植周期中囊胚形态、β - hcg阳性和妊娠存活率的影响
IF 0.7 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-01 Epub Date: 2025-01-22 DOI: 10.1007/s13224-024-02079-0
Doel Bose Pande, Hemant Deshmukh, Shivani Bhadauria, Gajendra Singh Tomar

Background: This study was conducted to explore the impact of male age, sperm concentration and motility, on the blastocyst expansion, inner cell mass and trophectoderm grade of the blastocyst along with beta-HCG positivity and viability of pregnancy following a frozen embryo transfer.

Materials and methods: Data from Indore Infertility Clinic from January 2021 to December 2023 were utilized. ICSI cycles with a single frozen embryo transfer were used for analysis. Statistical analyses were performed using STATA-13/IC software and Microsoft Excel Professional Plus 2021.

Results: No significant correlation was found between male age and sperm concentration or motility. A positive correlation between sperm concentration and motility was observed in autologous sperm samples. There was no significant association between male age, sperm concentration and sperm motility with blastocyst expansion, inner cell mass grade or trophectoderm grade. No significant association was found between male age, sperm concentration and sperm motility with beta-HCG. A significant association was observed between inner cell mass grade and beta-HCG positivity. No significant association was found between cardiac activity and blastocyst morphology, male age, sperm concentration and motility.

Conclusion: This study did not reveal any significant associations between male age, semen parameters and blastocyst morphology. No association was found between male age, semen parameters to beta-HCG positivity and pregnancy viability. A significant association was found between quality of inner cell mass and beta-HCG positivity in autologous semen sample cases.

背景:本研究旨在探讨男性年龄、精子浓度和活力对冷冻胚胎移植后囊胚扩张、内细胞质量和滋养外胚层等级以及β - hcg阳性和妊娠存活率的影响。材料与方法:采用2021年1月至2023年12月印度不孕不育诊所的数据。单冷冻胚胎移植的ICSI周期用于分析。使用STATA-13/IC软件和Microsoft Excel Professional Plus 2021进行统计分析。结果:男性年龄与精子浓度、活力无显著相关性。在自体精子样本中,精子浓度与活力呈正相关。男性年龄、精子浓度和精子活力与囊胚膨胀、内细胞团块分级和滋养外胚层分级无显著相关性。男性年龄、精子浓度和精子活力与β - hcg之间未发现显著关联。观察到内细胞质量分级与β - hcg阳性之间存在显著关联。心脏活动与囊胚形态、男性年龄、精子浓度和活力无显著关联。结论:本研究未发现男性年龄、精液参数与囊胚形态有显著相关性。未发现男性年龄、精液参数与β - hcg阳性和妊娠存活率之间存在关联。在自体精液样本病例中,发现内细胞质量与β - hcg阳性之间存在显著关联。
{"title":"Impact of Male Age and Semen Parameters on Blastocyst Morphology, Beta-HCG Positivity and Pregnancy Viability: A Retrospective Analysis in Frozen Embryo Transfer Cycles.","authors":"Doel Bose Pande, Hemant Deshmukh, Shivani Bhadauria, Gajendra Singh Tomar","doi":"10.1007/s13224-024-02079-0","DOIUrl":"10.1007/s13224-024-02079-0","url":null,"abstract":"<p><strong>Background: </strong>This study was conducted to explore the impact of male age, sperm concentration and motility, on the blastocyst expansion, inner cell mass and trophectoderm grade of the blastocyst along with beta-HCG positivity and viability of pregnancy following a frozen embryo transfer.</p><p><strong>Materials and methods: </strong>Data from Indore Infertility Clinic from January 2021 to December 2023 were utilized. ICSI cycles with a single frozen embryo transfer were used for analysis. Statistical analyses were performed using STATA-13/IC software and Microsoft Excel Professional Plus 2021.</p><p><strong>Results: </strong>No significant correlation was found between male age and sperm concentration or motility. A positive correlation between sperm concentration and motility was observed in autologous sperm samples. There was no significant association between male age, sperm concentration and sperm motility with blastocyst expansion, inner cell mass grade or trophectoderm grade. No significant association was found between male age, sperm concentration and sperm motility with beta-HCG. A significant association was observed between inner cell mass grade and beta-HCG positivity. No significant association was found between cardiac activity and blastocyst morphology, male age, sperm concentration and motility.</p><p><strong>Conclusion: </strong>This study did not reveal any significant associations between male age, semen parameters and blastocyst morphology. No association was found between male age, semen parameters to beta-HCG positivity and pregnancy viability. A significant association was found between quality of inner cell mass and beta-HCG positivity in autologous semen sample cases.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 3","pages":"206-212"},"PeriodicalIF":0.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12204959/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144531052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reference Range of Thyroid Hormones in Pregnancy: Customization Needed for Pregnant Women in India. 妊娠期甲状腺激素参考范围:印度孕妇需要定制
IF 0.7 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-01 Epub Date: 2025-05-13 DOI: 10.1007/s13224-025-02117-5
Nalini Arora, Pallavi Kashyap, Dipankar Saren, Priyanka Meel, Joya Ghosh, Ashish Yadav

Background: The precise interpretation of thyroid function tests during pregnancy needs population-based trimester-specific data among pregnant women. This study was to determine trimester-specific reference range for free triiodothyronine (FT3), free thyroxine (FT4) and thyrotropin (TSH) among pregnant women in India.

Methods: In this prospective observational study, asymptomatic pregnant women with single fetus were enrolled from each trimester. Serum FT3, FT4, TSH and anti-thyroperoxidase (anti-TPO) antibodies were estimated using electrochemiluminescence technique.

Results: Among 918 pregnant women, 82 women were excluded due to the presence of anti-TPO antibodies (76) and overt hypothyroidism (6). Among the remaining 836 women, 279 (33.3%) were in first trimester, 309 (36.9%) in second and 248 (29.6%) in third trimester. The 5th and 95th percentile values for each trimester were used as reference ranges. For all three hormones, the reference ranges for the first, second and third trimesters were: FT3 (1.59-3.64, 1.60-3.50 and 1.44-3.28 pg/dl), FT4 (0.64-1.12, 0.64-1.05 and 0.60-1.01 ng/dl) and TSH (0.21-4.95, 0.23-4.90 and 0.14-4.59 µIU/ml). The mean and median values for TSH between each trimester showed no statistically significant difference. No specific trend was seen for FT3 and TSH with advancing gestation. FT4 showed a decreasing trend with advancing trimester (P value: first versus second = 0.01, first versus third = 0.00003 and second versus third = 0.004). The reference range (N = 836) irrespective of trimester for thyroid hormones was: FT3 (1.53-3.46 pg/dl), FT4 (0.63-1.08 ng/dl) and TSH (0.19-4.72 µIU/ml).

Conclusion: The trimester-specific reference levels of TSH among pregnant women from India are significantly higher than 4 mIU/L (American Thyroid Association 2017).

背景:孕期甲状腺功能检测的精确解释需要孕妇基于人群的孕期特异性数据。本研究旨在确定印度孕妇游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)和促甲状腺素(TSH)的孕期特异性参考范围。方法:在这项前瞻性观察研究中,无症状的单胎妊娠妇女从每个三个月开始入组。电化学发光法测定血清FT3、FT4、TSH和抗甲状腺过氧化物酶(anti-TPO)抗体。结果:918例孕妇中,82例因存在抗tpo抗体(76例)和明显的甲状腺功能减退(6例)而被排除。在其余836名妇女中,279名(33.3%)处于妊娠早期,309名(36.9%)处于妊娠中期,248名(29.6%)处于妊娠晚期。每三个月的第5和第95百分位值作为参考范围。对于所有三种激素,孕早期、中期和晚期的参考范围分别为:FT3(1.59-3.64、1.60-3.50和1.44-3.28 pg/dl)、FT4(0.64-1.12、0.64-1.05和0.60-1.01 ng/dl)和TSH(0.21-4.95、0.23-4.90和0.14-4.59 μ IU/ml)。各妊娠期TSH的平均值和中位数无统计学差异。妊娠晚期FT3和TSH没有明显的变化趋势。FT4随妊娠进展呈下降趋势(P值:第一对第二= 0.01,第一对第三= 0.00003,第二对第三= 0.004)。不同孕期甲状腺激素的参考范围(N = 836)为:FT3 (1.53-3.46 pg/dl), FT4 (0.63-1.08 ng/dl)和TSH (0.19-4.72 μ IU/ml)。结论:印度孕妇妊娠期TSH特异性参考水平显著高于4 mIU/L (American Thyroid Association 2017)。
{"title":"Reference Range of Thyroid Hormones in Pregnancy: Customization Needed for Pregnant Women in India.","authors":"Nalini Arora, Pallavi Kashyap, Dipankar Saren, Priyanka Meel, Joya Ghosh, Ashish Yadav","doi":"10.1007/s13224-025-02117-5","DOIUrl":"10.1007/s13224-025-02117-5","url":null,"abstract":"<p><strong>Background: </strong>The precise interpretation of thyroid function tests during pregnancy needs population-based trimester-specific data among pregnant women. This study was to determine trimester-specific reference range for free triiodothyronine (FT3), free thyroxine (FT4) and thyrotropin (TSH) among pregnant women in India.</p><p><strong>Methods: </strong>In this prospective observational study, asymptomatic pregnant women with single fetus were enrolled from each trimester. Serum FT3, FT4, TSH and anti-thyroperoxidase (anti-TPO) antibodies were estimated using electrochemiluminescence technique.</p><p><strong>Results: </strong>Among 918 pregnant women, 82 women were excluded due to the presence of anti-TPO antibodies (76) and overt hypothyroidism (6). Among the remaining 836 women, 279 (33.3%) were in first trimester, 309 (36.9%) in second and 248 (29.6%) in third trimester. The 5th and 95th percentile values for each trimester were used as reference ranges. For all three hormones, the reference ranges for the first, second and third trimesters were: FT3 (1.59-3.64, 1.60-3.50 and 1.44-3.28 pg/dl), FT4 (0.64-1.12, 0.64-1.05 and 0.60-1.01 ng/dl) and TSH (0.21-4.95, 0.23-4.90 and 0.14-4.59 µIU/ml). The mean and median values for TSH between each trimester showed no statistically significant difference. No specific trend was seen for FT3 and TSH with advancing gestation. FT4 showed a decreasing trend with advancing trimester (P value: first versus second = 0.01, first versus third = 0.00003 and second versus third = 0.004). The reference range (<i>N</i> = 836) irrespective of trimester for thyroid hormones was: FT3 (1.53-3.46 pg/dl), FT4 (0.63-1.08 ng/dl) and TSH (0.19-4.72 µIU/ml).</p><p><strong>Conclusion: </strong>The trimester-specific reference levels of TSH among pregnant women from India are significantly higher than 4 mIU/L (American Thyroid Association 2017).</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 3","pages":"246-252"},"PeriodicalIF":0.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12204971/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144531059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting Global Coverage: Comparison of In-Hospital OGTT at 2-3 Days Postpartum with OGTT at 6-12 Weeks Postpartum for Predicting Glucose Intolerance in Postpartum Women with Gestational Diabetes Mellitus. 针对全球覆盖:产后2-3天住院OGTT与产后6-12周OGTT预测妊娠期糖尿病产后妇女葡萄糖耐受不良的比较
IF 0.7 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-01 Epub Date: 2025-06-12 DOI: 10.1007/s13224-025-02123-7
Pikee Saxena, Simran Kaur Arora, Anupam Prakash, Rajeev Chawla, Anjalakshi Chandrasekar, Hema Diwakar, Rajesh Jain, Veeraswamy Seshiah

Background: Recognizing the importance of postpartum testing for dysglycaemia after gestational diabetes mellitus (GDM), follow-up visit is recommended by all guidelines; unfortunately, dropout rate for follow-up is very high.

Objective: Comparison of diagnostic accuracy of early OGTT on day 2 or 3 postpartum with late OGTT at 6-12 weeks for predicting dysglycaemia in women with GDM in index pregnancy.

Methods: A total of 250 women with GDM underwent early WHO OGTT testing at 2-3 days postpartum, repeated at 6-12 weeks postpartum. Diagnostic accuracy, sensitivity, specificity, AUC, NPV, and PPV of early OGTT were calculated with 6-12 weeks OGTT as the gold standard.

Results: Of the 250 women, 100% completed glucose testing at 2-3 days postpartum while 86% returned at 6-12 weeks for repeat testing despite repetitive phone calls. At 2-3 days of testing, 26.80% women had impaired fasting glucose (IFT), 26.40% women had impaired glucose tolerance (IGT), and 3.20% women had DM. At 6-12 weeks testing, 25% had IFT, 29.81% had IGT. Early OGTT had a sensitivity of 86.15%, specificity of 91.61%, AUC of 0.89, NPV of 93.57%, PPV of 82.35% for predicting dysglycaemia. 51.6% were found to be suffering from metabolic syndrome during 2nd postpartum visit.

Conclusion: Early OGTT has the advantage of 100% coverage of women with GDM and may have comparable accuracy to conventional OGTT at 6-12 weeks postpartum in detecting impaired glucose status. Counselling and appropriate intervention before discharge may support prevention or delay the progression of diabetes and associated metabolic disorders.

背景:认识到妊娠期糖尿病(GDM)产后血糖异常检测的重要性,所有指南都推荐随访;不幸的是,随访的辍学率非常高。目的:比较产后2、3天早期OGTT与6 ~ 12周晚期OGTT对指数妊娠期GDM患者血糖异常的诊断准确性。方法:共有250名GDM妇女在产后2-3天接受早期WHO OGTT检测,并在产后6-12周重复检测。以6-12周OGTT为金标准,计算早期OGTT的诊断准确性、敏感性、特异性、AUC、NPV、PPV。结果:在250名妇女中,100%的人在产后2-3天完成了血糖测试,86%的人在6-12周时返回,尽管有重复的电话重复测试。在2-3天的测试中,26.80%的女性空腹血糖(IFT)受损,26.40%的女性葡萄糖耐量(IGT)受损,3.20%的女性患有糖尿病。在6-12周的测试中,25%的女性空腹血糖(IFT)受损,29.81%的女性空腹血糖(IGT)受损。早期OGTT预测血糖异常的敏感性为86.15%,特异性为91.61%,AUC为0.89,NPV为93.57%,PPV为82.35%。51.6%的产妇在产后第二次回访时出现代谢综合征。结论:早期OGTT具有100%覆盖GDM妇女的优势,并且在产后6-12周检测血糖受损状态方面可能具有与传统OGTT相当的准确性。出院前的咨询和适当的干预可能有助于预防或延缓糖尿病和相关代谢紊乱的进展。
{"title":"Targeting Global Coverage: Comparison of In-Hospital OGTT at 2-3 Days Postpartum with OGTT at 6-12 Weeks Postpartum for Predicting Glucose Intolerance in Postpartum Women with Gestational Diabetes Mellitus.","authors":"Pikee Saxena, Simran Kaur Arora, Anupam Prakash, Rajeev Chawla, Anjalakshi Chandrasekar, Hema Diwakar, Rajesh Jain, Veeraswamy Seshiah","doi":"10.1007/s13224-025-02123-7","DOIUrl":"10.1007/s13224-025-02123-7","url":null,"abstract":"<p><strong>Background: </strong>Recognizing the importance of postpartum testing for dysglycaemia after gestational diabetes mellitus (GDM), follow-up visit is recommended by all guidelines; unfortunately, dropout rate for follow-up is very high.</p><p><strong>Objective: </strong>Comparison of diagnostic accuracy of early OGTT on day 2 or 3 postpartum with late OGTT at 6-12 weeks for predicting dysglycaemia in women with GDM in index pregnancy.</p><p><strong>Methods: </strong>A total of 250 women with GDM underwent early WHO OGTT testing at 2-3 days postpartum, repeated at 6-12 weeks postpartum. Diagnostic accuracy, sensitivity, specificity, AUC, NPV, and PPV of early OGTT were calculated with 6-12 weeks OGTT as the gold standard.</p><p><strong>Results: </strong>Of the 250 women, 100% completed glucose testing at 2-3 days postpartum while 86% returned at 6-12 weeks for repeat testing despite repetitive phone calls. At 2-3 days of testing, 26.80% women had impaired fasting glucose (IFT), 26.40% women had impaired glucose tolerance (IGT), and 3.20% women had DM. At 6-12 weeks testing, 25% had IFT, 29.81% had IGT. Early OGTT had a sensitivity of 86.15%, specificity of 91.61%, AUC of 0.89, NPV of 93.57%, PPV of 82.35% for predicting dysglycaemia. 51.6% were found to be suffering from metabolic syndrome during 2nd postpartum visit.</p><p><strong>Conclusion: </strong>Early OGTT has the advantage of 100% coverage of women with GDM and may have comparable accuracy to conventional OGTT at 6-12 weeks postpartum in detecting impaired glucose status. Counselling and appropriate intervention before discharge may support prevention or delay the progression of diabetes and associated metabolic disorders.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 3","pages":"253-257"},"PeriodicalIF":0.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12204957/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144531062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Profile and Intra-Hospital Outcomes of Peripartum Cardiomyopathy in Ibadan, Nigeria. 尼日利亚伊巴丹围产期心肌病的临床概况和院内结局
IF 0.7 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-01 Epub Date: 2025-04-04 DOI: 10.1007/s13224-025-02116-6
Okechukwu S Ogah, Olanike A Orimolade, Akinyemi Aje, Oluwabunmi C Adeyeye, Abdulhammed O Babatunde, Fisayo Ogah, Oreoluwa J Alabi, Chioma F Obiorah, Chukwuebuka S Asogwa, Temitope Ilori, Gbolahan Obajimi, Abiodun M Adeoye, Olulola O Oladapo, Adewole A Adebiyi

Aim: The clinical profile of the disease in southern Nigeria is less reported. This study aims to describe the clinical characteristics and intra-hospital outcomes of PPCM in Ibadan, south-west Nigeria.

Materials and methods: We reviewed 69 cases of PPCM seen in Nigerian Women at the University College Hospital Ibadan between 2006 and 2021.

Results: The mean age at presentation was 30.5 ± 6.7 years (age range 18 - 46 years). The mean BMI was 23.5 kg/M2. Most were from the low socio-economic group (47/68.1%) and presented postpartum. The majority were primipara; twin pregnancy was seen in four (5.8%), and PIH occurred in 10 (14.5%) cases. Heart failure was the most typical mode of presentation. Over 90% of the women had spontaneous vertex delivery. Fetal death was recorded in three (4.3%). Two women died. Both presented with severe heart failure and died within few days on admission.

Conclusion: PPCM in Ibadan, Nigeria, is relatively a disease of primipara from poor homes and in unbooked pregnant women. Improvement in maternal health will be invaluable in prevention of the condition in Nigeria.

Graphical abstract:

目的:尼日利亚南部该病的临床概况报道较少。本研究旨在描述尼日利亚西南部伊巴丹PPCM的临床特征和院内结果。材料和方法:我们回顾了2006年至2021年间在伊巴丹大学学院医院的69例尼日利亚妇女PPCM。结果:平均发病年龄为30.5±6.7岁(年龄范围18 ~ 46岁)。平均BMI为23.5 kg/M2。大多数来自低社会经济群体(47/68.1%),产后出现。大多数是初产妇;双胎妊娠4例(5.8%),妊高征10例(14.5%)。心衰是最典型的表现形式。超过90%的妇女自发顶点分娩。3例胎儿死亡(4.3%)。两名妇女死亡。两人都表现出严重的心力衰竭,并在入院几天内死亡。结论:在尼日利亚伊巴丹,PPCM是贫困家庭初产妇和未预约孕妇的主要疾病。改善产妇保健对尼日利亚预防这一疾病具有不可估量的价值。图形化的简介:
{"title":"Clinical Profile and Intra-Hospital Outcomes of Peripartum Cardiomyopathy in Ibadan, Nigeria.","authors":"Okechukwu S Ogah, Olanike A Orimolade, Akinyemi Aje, Oluwabunmi C Adeyeye, Abdulhammed O Babatunde, Fisayo Ogah, Oreoluwa J Alabi, Chioma F Obiorah, Chukwuebuka S Asogwa, Temitope Ilori, Gbolahan Obajimi, Abiodun M Adeoye, Olulola O Oladapo, Adewole A Adebiyi","doi":"10.1007/s13224-025-02116-6","DOIUrl":"10.1007/s13224-025-02116-6","url":null,"abstract":"<p><strong>Aim: </strong>The clinical profile of the disease in southern Nigeria is less reported. This study aims to describe the clinical characteristics and intra-hospital outcomes of PPCM in Ibadan, south-west Nigeria.</p><p><strong>Materials and methods: </strong>We reviewed 69 cases of PPCM seen in Nigerian Women at the University College Hospital Ibadan between 2006 and 2021.</p><p><strong>Results: </strong>The mean age at presentation was 30.5 ± 6.7 years (age range 18 - 46 years). The mean BMI was 23.5 kg/M<sup>2</sup>. Most were from the low socio-economic group (47/68.1%) and presented postpartum. The majority were primipara; twin pregnancy was seen in four (5.8%), and PIH occurred in 10 (14.5%) cases. Heart failure was the most typical mode of presentation. Over 90% of the women had spontaneous vertex delivery. Fetal death was recorded in three (4.3%). Two women died. Both presented with severe heart failure and died within few days on admission.</p><p><strong>Conclusion: </strong>PPCM in Ibadan, Nigeria, is relatively a disease of primipara from poor homes and in unbooked pregnant women. Improvement in maternal health will be invaluable in prevention of the condition in Nigeria.</p><p><strong>Graphical abstract: </strong></p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 3","pages":"238-245"},"PeriodicalIF":0.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205104/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144530964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rise and Rise of Endometriosis-An Enigma. 子宫内膜异位症的兴起-一个谜。
IF 0.7 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-01 Epub Date: 2025-06-20 DOI: 10.1007/s13224-025-02176-8
Sujata Dalvi

Endometriosis is considered 'silent disease' but is debilitating that impacts quality of life. It is chronic, benign condition which is oestrogen dependent and has chronic inflammatory component. Endometriosis is associated with menstruation with increased sensitivity to oestrogen receptors and with low progesterone levels. Locally produced prostaglandins from endometriotic lesions leads to pain. There is delay in diagnosis by several years, as symptoms are not specific. This can lead to decline in fertility and quality of life. Imaging techniques and bio markers are not very specific but definitive diagnosis can be with Laparoscopy and histopathology. The first line of therapy will be medical, for relief of pain and fertility. Surgery is advised after failure of medical therapy, for severe degree of disease and deep infiltrating endometriosis (DIE). Assisted reproductive technology (ART) therapy is proposed for improved fertility outcome after surgery. Recurrence is known to occur after therapy.

子宫内膜异位症被认为是“无声的疾病”,但会使人衰弱,影响生活质量。它是一种慢性的良性疾病,依赖于雌激素,并具有慢性炎症成分。子宫内膜异位症与月经有关,对雌激素受体的敏感性增加,孕激素水平低。子宫内膜异位症病变局部产生的前列腺素导致疼痛。由于症状不明确,诊断会延迟数年。这可能导致生育能力和生活质量下降。影像技术和生物标记不是非常具体,但明确的诊断可以通过腹腔镜检查和组织病理学。第一道治疗将是医学治疗,以减轻疼痛和生育能力。对于病情严重和深度浸润性子宫内膜异位症(DIE),建议在药物治疗失败后进行手术。辅助生殖技术(ART)治疗被建议用于改善手术后的生育结果。治疗后复发是已知的。
{"title":"Rise and Rise of Endometriosis-An Enigma.","authors":"Sujata Dalvi","doi":"10.1007/s13224-025-02176-8","DOIUrl":"10.1007/s13224-025-02176-8","url":null,"abstract":"<p><p>Endometriosis is considered 'silent disease' but is debilitating that impacts quality of life. It is chronic, benign condition which is oestrogen dependent and has chronic inflammatory component. Endometriosis is associated with menstruation with increased sensitivity to oestrogen receptors and with low progesterone levels. Locally produced prostaglandins from endometriotic lesions leads to pain. There is delay in diagnosis by several years, as symptoms are not specific. This can lead to decline in fertility and quality of life. Imaging techniques and bio markers are not very specific but definitive diagnosis can be with Laparoscopy and histopathology. The first line of therapy will be medical, for relief of pain and fertility. Surgery is advised after failure of medical therapy, for severe degree of disease and deep infiltrating endometriosis (DIE). Assisted reproductive technology (ART) therapy is proposed for improved fertility outcome after surgery. Recurrence is known to occur after therapy.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 3","pages":"185-191"},"PeriodicalIF":0.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205118/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144531060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Obstetrics and Gynecology of India
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1